Spero Therapeutics Inc (SPRO)
1.42
-0.01
(-0.70%)
USD |
NASDAQ |
Apr 24, 16:00
1.42
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Cash from Operations (TTM): -33.00M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -33.00M |
September 30, 2023 | 28.98M |
June 30, 2023 | 12.11M |
March 31, 2023 | 7.639M |
December 31, 2022 | -7.731M |
September 30, 2022 | -79.56M |
June 30, 2022 | -83.56M |
March 31, 2022 | -77.09M |
December 31, 2021 | -64.35M |
September 30, 2021 | -53.38M |
June 30, 2021 | -69.69M |
March 31, 2021 | -78.02M |
December 31, 2020 | -85.87M |
Date | Value |
---|---|
September 30, 2020 | -86.86M |
June 30, 2020 | -75.25M |
March 31, 2020 | -62.42M |
December 31, 2019 | -50.02M |
September 30, 2019 | -46.16M |
June 30, 2019 | -42.02M |
March 31, 2019 | -38.59M |
December 31, 2018 | -39.62M |
September 30, 2018 | -38.86M |
June 30, 2018 | -43.86M |
March 31, 2018 | -44.09M |
December 31, 2017 | -39.11M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-86.86M
Minimum
Sep 2020
28.98M
Maximum
Sep 2023
-49.80M
Average
-62.42M
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
Retractable Technologies Inc | 2.767M |
OptiNose Inc | -20.53M |
scPharmaceuticals Inc | -59.24M |
electroCore Inc | -14.67M |
Equillium Inc | -21.78M |